Agmatine suppresses glycolysis via the PI3K /Akt/ mTOR / HIF ‐1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide
BioFactors · 2025
DOI: 10.1002/biof.2149 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Katarina Milosevic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic"-National Institute of Republic of Serbia, University of Belgrade, Be…. Hauptthemen laut MEDLINE: Microglia, Mitochondria, Agmatine. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovation of the Republic of Serbia.
Abstract (Originalsprache)
Modulating metabolic pathways in activated microglia can alter their phenotype, which is relevant in uncontrolled neuroinflammation as a component of various neurodegenerative diseases. Here, we investigated how pretreatment with agmatine, an endogenous polyamine, affects metabolic changes in an in vitro model of neuroinflammation, a murine microglial BV‐2 cell line exposed to lipopolysaccharide (LPS). Hence, we analyzed gene expression using qPCR and protein levels using Western blot and ELISA. Microglial metabolic status was assessed by measuring lactate release and cellular ATP by enzymatic and luminescence spectrophotometry. Mitochondrial functionality was analyzed by fluorescent probes detecting mitochondrial membrane potential (mtMP) and superoxide production. Our findings suggest that kinase pathways associated with hypoxia‐inducible factor‐1α (HIF‐1α) regulate energy metabolism in pro‐inflammatory activated microglia. We have shown that LPS induces HIF‐1α and genes for glucose transporter and glycolytic rate, increases lactate production and causes mitochondrial dysfunction, suggesting a metabolic shift towards glycolysis. Agmatine inhibits the PI3K/Akt pathway and negatively regulates mammalian target of rapamycin (mTOR) phosphorylation and HIF‐1α levels, reducing lactate and tumor necrosis factor (TNF) production, which is supported by pharmacological blockade of PI3K. Pretreatment with agmatine also rescues mitochondrial function by counteracting the LPS‐induced decline in mtMP and increase in mitochondrial superoxide, resulting in an anti‐apoptotic effect. Agmatine alone increases intracellular ATP levels and maintains this effect even under pro‐inflammatory conditions. Our study emphasizes the ability of agmatine to engage in metabolic reprogramming of pro‐inflammatory microglia through increased ATP production and modulation of signaling pathway involved in promoting glycolysis and cytokine release.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Institute for Biological Research "Sinisa Stankovic"-National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
- Medical Faculty of the Military Medical Academy, University of Defense in Belgrade, Belgrade, Serbia.
- Department for General Physiology and Biophysics, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
ORCID-Profile: Katarina Milosevic, Ana Milosevic, Anica Zivkovic, Danijela Laketa, Marija M Janjic, Ivana Bjelobaba, Irena Lavrnja, Danijela Savic
Förderung
- Ministry of Science, Technological Development and Innovation of the Republic of Serbia
Zitieren
APA
Milosevic, K., Milosevic, A., Stevanovic, I., Zivkovic, A., Laketa, D., Janjic, M. M., Bjelobaba, I., Lavrnja, I., & Savic, D. (2025). Agmatine suppresses glycolysis via the PI3K /Akt/ mTOR / HIF ‐1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide. BioFactors. https://doi.org/10.1002/biof.2149
Vancouver
Milosevic K, Milosevic A, Stevanovic I, Zivkovic A, Laketa D, Janjic MM, et al. Agmatine suppresses glycolysis via the PI3K /Akt/ mTOR / HIF ‐1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide. BioFactors. 2025. doi:10.1002/biof.2149
BibTeX
@article{Milosevic2025,
author = {Milosevic, Katarina and Milosevic, Ana and Stevanovic, Ivana and Zivkovic, Anica and Laketa, Danijela and Janjic, Marija M and Bjelobaba, Ivana and Lavrnja, Irena and Savic, Danijela},
title = {Agmatine suppresses glycolysis via the PI3K /Akt/ mTOR / HIF ‐1α signaling pathway and improves mitochondrial function in microglia exposed to lipopolysaccharide},
journal = {BioFactors},
year = {2025},
doi = {10.1002/biof.2149}
}
EUVIMED